CE vs RNXT · rev $10.28B vs rev $266.0K
Celanese Corporation (CE) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
CE currently screens at market cap $5.92B. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the CE and RNXT stock pages for the full models.
Not investment advice.